developments in Recombinant Human Serum Albumin for Biopharmaceutical purposes
Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, presenting promising breakthroughs throughout various clinical and industrial applications. With its structural similarity to Obviously derived human serum albumin, OsrHSA offers a safer, much more dependable substitute for therapeutic use